Identifying previously unknown adverse drug reactions becomes more important as the number of drugs and the extent of their use increases. The aim of this Master’s thesis project was to evaluate the performance of a novel approach for highlighting potential adverse drug reactions, also known as signal detection. The approach was based on deviating time-to-onset patterns and was implemented as a two-sample Kolmogorov-Smirnov test for non-vaccine data in the safety report database, VigiBase. The method was outperformed by both disproportionality analysis and the multivariate predictive model vigiRank. Performance estimates indicate that deviating time-to-onset patterns is not a suitable approach for signal detection for non-vaccine data in Vi...
PURPOSE: In pharmacovigilance, the commonly used disproportionality analysis (DPA) in statistical si...
Background: Drug safety monitoring relies primarily on spontaneous reporting, but electronic health ...
National voluntary reporting systems generate large volumes of clinical data pertinent to drug safet...
BACKGROUND: Current quantitative signal detection methods have been primarily developed for the purp...
Cornelius VR, Sauzet O, Evans SJW. A Signal Detection Method to Detect Adverse Drug Reactions Using ...
Background Detection of unknown risks with marketed medicines is key to securing the optimal care of...
PURPOSE: In a previous study, we developed a signal detection method using the time to onset (TTO) o...
Signal detection from Adverse Event Reports (AERs) is important for identifying and analysing drug s...
Statistical methods can be helpful in detecting adverse drug reactions.When a drug enters the market...
Computational approaches to detect the signals of adverse drug reactions are powerful tools to monit...
The Author(s) 2014. This article is published with open access at Springerlink.com Background Detect...
The primary aim of spontaneous reporting systems (SRSs) is the timely detection of unknown adverse d...
Sauzet O, Cornelius V. Generalised weibull model-based approaches to detect non-constant hazard to s...
PURPOSE: Signal detection is a crucial step in the discovery of post-marketing adverse drug reaction...
PURPOSE: The statistical screening of pharmacovigilance databases containing spontaneously reported ...
PURPOSE: In pharmacovigilance, the commonly used disproportionality analysis (DPA) in statistical si...
Background: Drug safety monitoring relies primarily on spontaneous reporting, but electronic health ...
National voluntary reporting systems generate large volumes of clinical data pertinent to drug safet...
BACKGROUND: Current quantitative signal detection methods have been primarily developed for the purp...
Cornelius VR, Sauzet O, Evans SJW. A Signal Detection Method to Detect Adverse Drug Reactions Using ...
Background Detection of unknown risks with marketed medicines is key to securing the optimal care of...
PURPOSE: In a previous study, we developed a signal detection method using the time to onset (TTO) o...
Signal detection from Adverse Event Reports (AERs) is important for identifying and analysing drug s...
Statistical methods can be helpful in detecting adverse drug reactions.When a drug enters the market...
Computational approaches to detect the signals of adverse drug reactions are powerful tools to monit...
The Author(s) 2014. This article is published with open access at Springerlink.com Background Detect...
The primary aim of spontaneous reporting systems (SRSs) is the timely detection of unknown adverse d...
Sauzet O, Cornelius V. Generalised weibull model-based approaches to detect non-constant hazard to s...
PURPOSE: Signal detection is a crucial step in the discovery of post-marketing adverse drug reaction...
PURPOSE: The statistical screening of pharmacovigilance databases containing spontaneously reported ...
PURPOSE: In pharmacovigilance, the commonly used disproportionality analysis (DPA) in statistical si...
Background: Drug safety monitoring relies primarily on spontaneous reporting, but electronic health ...
National voluntary reporting systems generate large volumes of clinical data pertinent to drug safet...